APOC3 and Hyperglycemia: We observed that lowering APOC3 in Ai-DKO mice leads to downregulation of the expression of lipogenic genes in the liver and partially reverses the hypertriglyceridemia, but it does not affect hyperglycemia or hyperinsulinemia.